The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free DNA methylation markers for noninvasive early detection of nasopharyngeal carcinoma.
 
Dhruvajyoti Roy
Employment - Laboratory for Advanced Medicine
Travel, Accommodations, Expenses - Laboratory for Advanced Medicine
 
David J Taggart
Employment - The Laboratory for Advanced Medicine
Stock and Other Ownership Interests - Laboratory for Advanced Medicine
 
Lianghong Zheng
Employment - Laboratory for Advanced Medicine
 
Dan Liu
Employment - Laboratory for Advanced Medicine
Leadership - Laboratory for Advanced Medicine
Stock and Other Ownership Interests - Laboratory for Advanced Medicine
Honoraria - Laboratory for Advanced Medicine
Consulting or Advisory Role - Laboratory for Advanced Medicine
Research Funding - Laboratory for Advanced Medicine
 
Gen Li
Employment - Laboratory for Advanced Medicine
 
Mingzhen Li
Employment - Laboratory for Advanced Medicine
 
Kang Zhang
Employment - Laboratory for Advanced Medicine
Leadership - Laboratory for Advanced Medicine
Stock and Other Ownership Interests - Laboratory for Advanced Medicine
Honoraria - Laboratory for Advanced Medicine
Consulting or Advisory Role - Laboratory for Advanced Medicine
Research Funding - Laboratory for Advanced Medicine
Patents, Royalties, Other Intellectual Property - Laboratory for Advanced Medicine
Expert Testimony - Laboratory for Advanced Medicine
 
Richard A. Van Etten
Employment - Laboratory for Advanced Medicine
Leadership - Laboratory for Advanced Medicine
Patents, Royalties, Other Intellectual Property - UCI (Inst)
Expert Testimony - Pfizer